Risk of leukaemia with multiple sclerosis drug higher than thought

The risk of developing leukaemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study to be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, 25 April - 2 May 2009...

Read the whole article on

More from